In December 2017, a cross-party commission in the United Kingdom shared their findings: more than 9 million Brits, 14% of the population, experienced loneliness always or often, with 200,000 older adults not having had a conversation with a friend or relative in over a month. The commission had been established to honor Jo Cox, a Member of Parliament assassinated in 2016 who had championed the loneliness issue. It made a series of recommendations that Prime Minister Theresa May accepted the following month. Among them: the appointment of a Minister for Loneliness, the first such position in the world.
When Tracey Crouch became the world’s first Minister for Loneliness in 2018 amid Brexit, international headlines evinced bemusement. A Minister for Loneliness collaborating with the National Health Service (NHS) seemed a quintessentially British idea: earnest, well-intentioned, a tad stiff and academic, and ultimately reflecting a focus on social problems, not medical ones. Yet the commission’s data told a different story. Isolation was increasing the risk of heart disease and cognitive decline. The NHS was spending billions on socially isolated patients through increased hospitalizations and extended stays. Intervening seemed clinically critical.
Across the pond, nearly 10 years later, our approach to social isolation has not budged. Patients and society increasingly expect our profession to address upstream determinants of health: the roughly 80% of mortality risk driven by factors outside the clinic, like behavior, environment, and economics. In an odd way, this is an area of common ground in our polarized political sphere; both the “Make America Healthy Again” (MAHA) movement and the “Health Justice” initiative are demands of medicine to broaden its viewpoint and look at the root causes of health issues. In the case of social isolation, the question for U.S. health care is not whether we can afford to treat it, but whether we can afford not to. Physicians and policymakers must confront the evidence on social isolation as a cause of premature death, learn from international social-prescribing models, and translate those lessons into a pragmatic U.S. framework.
Social Isolation is Deadly — and Costly
The 2015 Holt-Lunstad meta-analysis offered some of the strongest evidence on loneliness as an independent, clinically significant risk factor for poor health. The headline: being chronically lonely or socially isolated raises the risk of premature death by 26%–32%. These effect sizes persist after controlling for baseline health status, health behaviors, and psychological factors such as depression. The health consequences go beyond mortality. According to the CDC, older adults who struggle with loneliness or isolation have a 29% higher risk of heart disease, a 32% higher risk of stroke, and a 50% increased risk of developing dementia. The evidence is consistent and robust; prospective cohort studies demonstrate loneliness predicting subsequent cardiovascular events, cognitive decline, and all-cause mortality.
More recently, mechanistic research has identified pathways that ground these statistics in biological reality. Isolation acts via well-characterized biological mechanisms such as sustained hypothalamic-pituitary-adrenal axis activation, elevated C-reactive protein and interleukin-6, and disrupted sleep architecture to cause mortality and morbidity.
This health impact of loneliness is also reflected in the economic data. An analysis of Medicare beneficiaries found that objectively isolated older adults (defined as patients just one standard deviation below the mean per a composite score which took into account data like number of family members and frequency of meetings) generated $1,644 in additional spending per person annually, concentrated in inpatient hospitalization and skilled nursing facility care. Extrapolated nationally, social isolation accounts for an estimated $6.7 billion in excess Medicare spending. Despite increased health care utilization, objectively isolated beneficiaries faced 31% greater mortality risk, suggesting that reactive medical care fails to address the underlying pathology.
Most research has focused only on the effects of isolation in the elderly. However, after the COVID-19 pandemic, it seems increasingly important to study loneliness in youth. Adolescent loneliness rates surged during lockdowns and have not returned to baseline. In response, many lonely youth have begun using new AI chatbots for companionship. While AI may soon give everyone a personal therapist, it's less clear whether they meaningfully address loneliness in a way that cuts mortality. Reliance on AI is concerning, as sycophancy has proven challenging to root out from the model training process. Though technocrats like Mark Zuckerberg excitedly imagine a future where every American has 15 friends — 12 of whom are AI — I am doubtful that an AI companion could challenge, surprise, and stimulate the brain in the way that novel interactions with people can. In the meantime, then-U.S. Surgeon General Vivek Murthy issued an advisory declaring loneliness and isolation an epidemic, comparing its mortality impact to smoking 15 cigarettes daily.
We routinely screen for, treat, and medicalize complex health issues with social determinants like tobacco use, obesity, and diabetes. But not social isolation. The evidence base suggests this is not medically warranted. Ignoring loneliness until it manifests as an advanced medical disorder is akin to only treating high cholesterol after the patient has a heart attack.
The Ministry of Loneliness: A Case Study
By October 2018, the UK government published its first national loneliness strategy, embedding “social prescribing” into the NHS. Under the NHS Long Term Plan, every primary care network in England would employ link workers: non-clinical staff trained to connect isolated patients with community resources. General practitioners could refer patients to link workers via their EHRs. Link workers meet with patients to connect them to community activities like walking groups, art classes, and volunteer opportunities. In 2023, the program reached 1.3 million patients annually, far exceeding initial goals.
The model succeeds because it leverages existing community assets rather than creating government systems. Most communities already have walking groups, libraries, volunteer organizations, and social clubs; link workers function as connective tissue — akin to patient navigators in the hospital — making these resources accessible to isolated individuals and offering frequent check-ins to encourage adherence. Systematic reviews report positive impacts on loneliness, well-being, and quality of life. A 2024 summary from the National Academy for Social Prescribing has provided the most promising evidence yet, with evaluations from specific hospital systems showing a 28% drop in GP visits and 24% fewer ED attendances in targeted populations.
U.S. Policy and the Path Forward
The U.S. faces unique challenges given the lack of a central NHS to coordinate the development and implementation of link workers. So what ought physicians do?
1) Routine Isolation Screening: Just as we check blood pressure, we should begin screening for loneliness and social isolation in primary care. We need to learn about and screen at-risk patients — those most affected by the digital displacement of in-person bonds, fragmented communities, and inaccessible public spaces. Strong clinical psychometric screening tools already exist, with the brief 5-item ALONE Scale demonstrating strong correlation with the landmark 20-question UCLA Loneliness Scale (r=0.81). Once identified, physicians must recognize isolation as a diagnosis warranting follow-up. We can ask about social networks, connect isolated patients to community resources, and plan reassessment. Physicians could begin utilizing diagnostic codes such as Z60.4, “social exclusion and rejection,” with clear documentation in the EHR. Such efforts will help support research at scale, creating useful databases of patient populations.
2) Academic Institution Leadership: Well-resourced settings and hospital environments are fortunate to have social work staff they can consult. Additional training as part of new pilot programs could allow these clinical members to act similarly to the UK’s link worker system. Cross-community partnerships are key. Hospitals should team up with local nonprofits, senior centers, faith groups, YMCAs, libraries, and beyond. Accountable care organizations have a business opportunity here: link workers could pay for themselves by reducing emergency visits and hospitalizations among isolated patients.
3) Government Advocacy: The problem of social isolation is too severe to wait for more clear political leadership. Savvy operators can push for targeted research funding and grants to study isolation interventions. Professional societies should work with CMS, HHS, and commercial payers to establish reimbursement for social prescribing. There is precedent: some Medicare Advantage insurers now cover meal deliveries and transportation. Pilot programs funded by CMS Innovation Center or state Medicaid waivers could test programs for high-risk patients. If the data show improved outcomes per dollar spent, these could be scaled.
4) Education: Health professionals need to be brought on board through training and culture change to manage isolation through our evidence-based medical lens. This means teaching future clinicians how to ask about social connections, empathize with loneliness, and engage interdisciplinary help rather than reflexively reaching for a prescription pad.
In the nearly 10 years since Britain appointed its Minister for Loneliness, the U.S.’s failure to act has showcased confusion about medicine’s proper scope. Sir William Osler, one of medicine’s founding figures, once said, “the good physician treats the disease; the great physician treats the patient who has the disease.” Look: doctors shouldn’t try to be social workers, but neither should we ignore a major driver of patient health when most of society, from MAHA to social medicine, expects us to do more. Programs to treat isolation are popular where implemented — patients report feeling “heard” and “cared for” in a way that traditional medical encounters often miss. As physicians, we will still wield stethoscopes and prescribe medications, but in the modern era, we must also be prepared to treat upstream ills. And as burnout and cynicism run high, prescribing connection can perhaps help to treat our own isolation, reconnecting us to why we entered the profession of healing in the first place.
Aditya Jain is an MD student at Harvard Medical School, and a researcher on applications of AI in medicine at the Broad. He is interested in the business of health care and its intersection with technology and policy. More of his writing can be found on Substack @adityajain42. Aditya was a 2023–2024 and a 2024–2025 Doximity Op-Med Fellow, and continues as a 2025–2026 Doximity Op-Med Fellow.
Image by GoodStudio / Shutterstock
